Phenylephrine HCl Injection recalled for lack of sterility assurance
Nephron Sterile Compounding Center is recalling Phenylephrine HCl Injection syringes nationwide due to lack of assurance of sterility affecting 76,860 units.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable medication with potential contamination risk due to lack of sterility assurance. No illnesses or injuries have been reported. The hazard represents a risk of harm to patients if administered, qualifying it as High severity per the rubric.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Phenylephrine HCl Injection, USP, 0.8 mg/10 mL due to lack of assurance of sterility. The recall affects 76,860 pre-filled syringes distributed nationwide. Affected lot numbers are PE1107A, PE1123A, PE2007A, and PE2012A, with expiration dates ranging from May 2022 to August 2022.
The manufacturer initiated the recall because it could not provide assurance that the product meets required sterility standards. Phenylephrine HCl Injection is an injectable medication. Patients and healthcare providers in possession of syringes from the affected lots should stop use immediately and contact Nephron Sterile Compounding Center or their healthcare provider for guidance on replacement or return of the product.
Anyone who has used this product and experienced adverse effects should report the event to the FDA's MedWatch program.
The recalled product
- Product
- Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Pre-Filled Syringes, 5 x 10 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-956-10
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable Medication
- Hazard
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lots: PE1107A
- Exp. 5/22/2022
- PE1123A
- Exp. 6/21/2022
- PE2007A
- Exp. 8/4/2022
- PE2012A
- Exp. 8/28/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27